Vivo Biosciences India Pvt. Ltd. is a new R&D subsidiary of US-based biotech company: Vivo Biosciences Inc. The Company is developing novel human bioassay platforms to accelerate drug discovery, preclinical and biomedical research.
Using its patented HuBiogel™ technology, Vivo Biosciences India has developed a series of new 3-D or tissue-like assay models emulating the biology of both normal and disease states. Their advanced bioassay system allows rapid analysis of drug efficacy, toxicity and therapeutic endpoints – the major bottlenecks of current drug discovery pipelines. It is enormously valuable for providing critical ‘go or no-go’ decisions prior to expensive clinical trials. Its technology, now available world-wide, is also adaptable to tissue engineering, cell therapeutics and functional genomics applications. The company has taken 6000 sqft built up space in the Park for its operations along with Cognate Bioservices.

-: For Further Detail Please Contact :-
Vivo Biosciences Inc.
Dr. Raj Singh
CEO
1601 12th Avenue South, Birmingham
AL 35205
Tel: (o) 205-930-0001 ext 102,(c) 205-937-3024
Email: rsingh@vivobiotech.com
website: www.vivobiotech.com